The theory of program-survival bias is much more plausible than it already is when the pivotal trial for a drug is the first double-blind, randomized trial.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.